Vitiligo - Diagnosis & treatment - Mayo Clinic
WEBNov 10, 2022 · The choice of treatment depends on your age, how much skin is involved and where, how quickly the disease is progressing, and how it's affecting your life. Medications and light-based therapies are available to help restore skin color or even out skin tone, though results vary and are unpredictable.
Vitiligo: Diagnosis and treatment - American Academy of …
WEBWhen treating vitiligo, board-certified dermatologists create a treatment plan with these goals in mind: Restore lost skin color. Stop the patches and spots from getting bigger.
Vitiligo Treatment: From Ointments to Depigmentation - Healthline
WEBFeb 16, 2024 · Light therapy, anti-inflammatory medications, cell transplants, and depigmentation are a few treatment options for vitiligo. Other approaches exist and they may depend on how...
FDA Approves New Vitiligo Treatment, Ruxolitinib (Opzelura)
WEBJul 22, 2022 · On July 18, the U.S. Food and Drug Administration (FDA) approved ruxolitinib (Opzelura) cream 1.5 percent as a treatment for the most common form of vitiligo, according to a statement by...
How Vitiligo Is Treated - Verywell Health
WEBAug 16, 2024 · Opzelura (ruxolitinib) cream is the first FDA-approved treatment for nonsegmental vitiligo in patients 12 years and older. It is also approved for treating atopic dermatitis. Opzelura works by downregulating the immune system, preventing the inflammation that causes vitiligo.
FDA approves topical treatment addressing repigmentation in …
WEBFDA has approved Opzelura (ruxolitinib) cream for the treatment of nonsegmental vitiligo in adult and pediatric patients 12 years of age and older.
Vitiligo: Current Therapies and Future Treatments - PMC
WEBDec 1, 2023 · The management of vitiligo should encompass three main complementary objectives: 1) halting disease progression, 2) inducing repigmentation, melanocyte regeneration and proliferation, and 3) maintaining repigmentation and preventing disease recurrence. Treating Patients with Active Disease.
Redefining Vitiligo Management: FDA-Approved Topical …
WEB2 days ago · Redefining Vitiligo Management: FDA-Approved Topical Ruxolitinib and the Evolving Treatment Paradigm. September 25, 2024. By Pearl Grimes, MD, FAAD. Opinion. Video. Pearl E. Grimes, MD, discusses the evolving treatment paradigm for vitiligo, highlighting the role of FDA-approved topical ruxolitinib and …
Vitiligo > Fact Sheets - Yale Medicine
WEBAlthough there is no cure for vitiligo, there may be hope. At Yale Medicine Dermatology, Dr. King is performing research on the use of a new class of medicines for the treatment of the disorder. What is vitiligo? Vitiligo is a disease that causes patches of skin to lose their color, resulting in white spots.
First step in a new era for treatment of patients with vitiligo
WEBJul 11, 2020 · Importantly, for optimal care of vitiligo patients, I emphasise three primary areas of concern: to stop the immune destruction of melanocytes to halt the depigmentation process, to induce the differentiation and proliferation of melanocyte stem cells for promoting repigmentation, and to prevent relapses when the repigmentation is achieved.
Skip to content